secwatch.observer — SEC 8-K summary
======================================

Issuer:     Minerva Neurosciences, Inc. (NERV)
CIK:        0001598646
Form:       8-K
Filed at:   2022-09-09T23:59:59+00:00
Accession:  0001193125-22-242001
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Minerva Neurosciences transfers stock listing to Nasdaq Capital Market to avoid delisting
--------------------------------------------------------------------------------

- Transfer from Nasdaq Global Market to Nasdaq Capital Market effective Sept 12, 2022; ticker NERV unchanged.
- Company was not in compliance with minimum $10M net equity requirement previously disclosed on March 8, 2022.
- Nasdaq approved transfer under Listing Rule 5810(c)(3)(A); company meets all Capital Market continued listing criteria.
- No impact on trading; press release issued Sept 9, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1598646/000119312522242001/0001193125-22-242001-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1598646/000119312522242001/d382794d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-242001

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer